Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 39.38 | - | - | - | 39.38 | 20:00:00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 218.63B | 5.55B | $ 11.15B | 1.90 | 21.00 | 5.55B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.44 | 3.66% | 01/31/2019 | -23.85k | 0.00% |
Pfizer News
Pfizer, Lilly Release Top-Line Results From Phase 3 Study of Tanezumab for Osteoarthritis Dow Jones News • Thu Apr 18, 2019 5:56 PM (4 days ago)
Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis Business Wire • Thu Apr 18, 2019 5:05 PM (4 days ago)
Pfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs Dow Jones News • Thu Apr 18, 2019 3:36 PM (4 days ago)
Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders Business Wire • Thu Apr 18, 2019 2:00 PM (4 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Apr 16, 2019 7:20 PM (5 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Apr 16, 2019 7:20 PM (5 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Apr 16, 2019 7:18 PM (5 days ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 41.86 | 42.3 | 38.42 | 40.1967 | 17M | 48M | 33M | -2.48 | -5.92% |
| 1 Month | 41.81 | 43.28 | 38.42 | 41.7403 | 12M | 48M | 21M | -2.43 | -5.81% |
| 3 Months | 40.54 | 43.79 | 38.1 | 41.9322 | 12M | 71M | 24M | -1.16 | -2.86% |
| 6 Months | 44.44 | 46.47 | 38.1 | 42.5758 | 8M | 71M | 23M | -5.06 | -11.39% |
| 1 Year | 36.67 | 46.47 | 34.37 | 41.1404 | 8M | 71M | 20M | 2.71 | 7.39% |
| 3 Years | 33.25 | 46.47 | 29.83 | 36.5017 | 6M | 113M | 20M | 6.13 | 18.44% |
| 5 Years | 30.85 | 46.47 | 27.51 | 34.1757 | 1k | 280M | 23M | 8.53 | 27.65% |
Pfizer Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
